OLBA Healthcare Holdings' consolidated ordinary profit for the fiscal year ended June 2026 came in at ¥1.66 billion, down 15.2% from the previous fiscal year and below the previous forecast. The company did not disclose its earnings outlook for the current fiscal year, and the annual dividend remains undecided.
OLBA Healthcare Holdings announced its results for the fiscal year ended June 2026. Consolidated ordinary profit came in at ¥1.66 billion, down approximately 15% from the previous fiscal year and below the previous forecast of ¥1.92 billion. Net sales increased from the previous fiscal year, but the decline in ordinary profit was notable.
In the latest April–June quarter (4Q), ordinary profit fell approximately 37% year on year to ¥420 million, while the operating profit margin declined from 2.3% to 1.4%. Profit growth therefore also slowed on a quarterly basis.
The company did not disclose its earnings outlook for the current fiscal year, and the annual dividend remains undecided. The specific outlook for its dividend policy therefore remains unclear.
A comparison of the previous fiscal year's results with the previous forecast shows net sales of ¥126,595 million, operating profit of ¥1,679 million, ordinary profit of ¥1,664 million and net income of ¥1,112 million. Overall, profit declined from the previous forecast.